(Q34992529)

5 August 2017

1 reference

title

Review article: volume expansion in patients with cirrhosis (English)

1 reference

5 August 2017

1 reference

Henriksen JH

1

1 reference

5 August 2017

Kiszka-Kanowitz M

series ordinal

2

1 reference

5 August 2017

Bendtsen F

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Alimentary Pharmacology & Therapeutics

5 August 2017

published in

1 reference

5 August 2017

volume

16 Suppl 5

1 reference

5 August 2017

page(s)

12-23

1 reference

Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Increased arterial compliance in decompensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Transport of macromolecules through microvascular walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Total effective vascular compliance in patients with cirrhosis. Effects of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

A new model of congestive heart failure in the mouse due to chronic volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

The physiological and pathophysiological modulation of the endocrine function of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

A prognostic model for predicting survival in cirrhosis with ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Whole-body protein turnover in malnourished patients with child class B and C cirrhosis on diets low to high in protein energy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

The Serum-Ascites Albumin Gradient Is Superior to the Exudate-Transudate Concept in the Differential Diagnosis of Ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Is there still a need for albumin infusions to treat patients with liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Human albumin administration in critically ill patients: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

On the Absorption of Fluids from the Connective Tissue Spaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

The sympathetic nervous system in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Increased metabolic turnover rate and transcapillary escape rate of albumin in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Aldosterone, atrial natriuretic factor and sodium intake as determinants of the natriuretic response to head-out water immersion in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Albumin Synthesis Rate as a Measure of Liver Function in Patients with Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Normal red cell cardiac output in the hyperkinetic syndrome of alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S5.3.X

10.1046/J.1365-2036.16.S5.3.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference